Document is current
Any future updates will be listed below
-
Authors
Gupta, Kapil https://orcid.org/0000-0002-2115-3503
Toelzer, Christine https://orcid.org/0000-0001-9984-5940
Williamson, Maia Kavanagh
Shoemark, Deborah K. https://orcid.org/0000-0002-1240-8463
Oliveira, A. Sofia F. https://orcid.org/0000-0001-8753-4950
Matthews, David A. https://orcid.org/0000-0003-4611-8795
Almuqrin, Abdulaziz
Staufer, Oskar https://orcid.org/0000-0002-8015-3132
Yadav, Sathish K. N.
Borucu, Ufuk
Garzoni, Frederic
Fitzgerald, Daniel
Spatz, Joachim https://orcid.org/0000-0003-3419-9807
Mulholland, Adrian J. https://orcid.org/0000-0003-1015-4567
Davidson, Andrew D.
Schaffitzel, Christiane https://orcid.org/0000-0002-1516-9760
Berger, Imre https://orcid.org/0000-0001-7518-9045
-
Funding
Funding for this research was provided by:
Wellcome Trust (106115/Z/14/Z)
RCUK | Engineering and Physical Sciences Research Council (EP/R013764/1, EP/R511663/1)
RCUK | Biotechnology and Biological Sciences Research Council (BB/P000940/1, BB/L01386X/1)
- License Information
-
More Information
Article History
Received: 28 June 2021
Accepted: 16 December 2021
First Online: 11 January 2022
Competing interests
: F.G. and I.B. report shareholding in Imophoron Ltd, unrelated to this Correspondence. D.F. and I.B. report shareholding in Geneva Biotech SARL, unrelated to this Correspondence. C.S., D.F., and I.B. report shareholding in Halo Therapeutics Ltd related to this Correspondence. Patent applications describing methods, material compositions and formulations based on the present observations have been filed. The remaining authors declare no competing interests.
